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namely clopidogrel, is an oral antiplatelet agent used 
to inhibit blood clots in coronary arteries,, peripheral 
vascular or cerebrovascular diseases and to prevent 
myocardial infarction (Fig. 1) (1).
Plavix® (clopidogrel), promoted by Sanofi-Aven-
tis and Bristol-Myers Squibb, was the second best-
selling drug in the world in 2010  (2). It irreversibly 
ABSTRACT
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ruggedness and robustness. The valid maximum absorbance was recorded at the 203 nm wavelength in the 
concentration ranges 1.0-2.6 mg/100mL of clopidogrel bisulphate in methanol solution after 15 min stirring. 
The limit of detection was found to be 0.59 mg/100mL, while the limit of quantification was 1.78mg/100mL. 
The calibration curve was linear with r2=0.9929. The proposed technique could be successfully used for 
the determination of clopidogrel bisulphate in bulk in small laboratories without LC−MS spectrometer or 
HPLC-UV chromatograph, as well as for future pharmacokinetic studies in pharmaceutical dosage forms.
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inhibits receptor P2Y12, an adenosine diphosphate 
chemoreceptor on platelet cell membranes (1). It is 
found, that in the first metabolization step the thio-
phene ring of clopidogrel is subjected to a mono-
oxygenation by hepatic cytochrome P450 isozymes 
(mainly CYP2C19), producing the corresponding 
2-oxo-clopidogrel intermediate, a thiolactone, which 
is further oxidized and undergoes a hydrolytic ring-
opening to be finally subjected to a glutathione-de-
pendent reduction giving the active thiol metabolites 
B and C (Fig. 1) (3). The augmented antiplatelet ef-
fects are expected, when co-prescribed with aspirin, 
curcumin, cyclosporine, rifampicine, and angioten-
sin-converting enzyme inhibitor (4). But the low ef-
ficacy of clopidogrel is estimated in the presence of 
Fig. 1. Structures of clopidogrel (A), and its active 
metabolites in E- (B) or Z-configuration (C)
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esomeprazole, morphine, grapefruit juice, scutella-
rin, fluoxetine, azole antifungals, calcium channel 
blockers, sulfonylureas and ritonavir.
According to the Paul W. Elsinghorst review 
and some others investigations about the quantita-
tive determination of clopidogrel, the predominant 
analysis techniques were LC–MS, LC–UV, GC–MS 
and LC–MS/MS, capillary zone electrophoresis cou-
pled with UV detection (3,5). Among drug interac-
tion studies, there were papers about clopidogrel bi-
sulfate and HMG Co-A reductase inhibitors (ator-
vastatin, pravastatin, simvastatin, rosuvastatin) via 
UV/VIS spectrophotometer at pH 1 or 4 (simulating 
gastric environments), pH 7.4 (simulating blood pH) 
and pH 9 (simulating intestinal pH) at body temper-
ature (37°C), or by a reversed-phase liquid chromato-
graphic method (6). Moreover, HPCE and HPLC 
methods were used for clopidogrel in bulk, for its 
pharmaceutical dosage forms (7-9). Recently, a sen-
sitive and fast UHPLC–MS/MS detection method 
was developed for clopidogrel and its active metabo-
lite H4 in human plasma (10). Even X-ray diffraction 
phase analysis for the mixtures of clopidogrel bisul-
phate polymorphs was proposed (11). In addition to 
that, a method based on the oxidation of 2,4-dinitro-
phenyl hydrazine and coupling of the oxidized prod-
uct with gemfibrozil and clopidogrel was found, re-
sulting in intensely colored chromogen, which had 
maximum absorbencies at the 421 nm and 412 nm 
(12).
Considering the absence of the appropriate ap-
paratuses like mass-spectrometers and HPLC chro-
matographs, and costs and time-limitations to con-
duct synthesis in the small analytical laboratories, it 
was decided to develop a novel low-cost, simple, fast 




The substance was weighed using analytical 
balances Kern ABT 120-5DM, KERN&Sohn GmbH, 
Germany. Methanol solutions were stirred using ul-
trasonic cleaning unit Elmasonic E/GB/0605, Elma 
Hans Schmidbauer GmbH&Co.KG, Germany. UV 
spectra were recorded on Analytic Jena UV-vis spec-
trophotometer Specord 200 (190-400 nm), Germany. 
Reagents and Solutions
All of the chemicals were of the highest puri-
ty available from LAB-SCAN (Ireland) and were 
used without any further purification. Distilled wa-
ter was used throughout the experiments. Working 
substance of clopidogrel bisulphate form II USP (as-
say by HPLC 100.40% w/w) was purchased from Glo-
chem Industries Limited, India.
Validation
Calibration curve. Standard solution (0.05%) 
was prepared by dissolving 0.0500 of the clopido-
grel in 100.0 mL flask with methanol with thorough 
stirring for 15 min. Several aliquots of standard so-
lution were taken quantitatively to make the next se-
ries of working standard solutions (%): 0.004, 0.0028, 
0.0026, 0.0024, 0.002, 0.0018, 0.0016, 0.0014, 0.0012, 
0.001, 0.0008, 0.0006, 0.0004, 0.0002 and 0.0001. All 
solutions were stored at 18–20 °C. 
The calibration curve of clopidogrel was con-
structed by UV-visible spectrophotometer absorp-
tion data, monitored 5 times for each sample, at the 
wavelength of maximum absorbance at the 203 nm 
in 3 mL cuvette with 1cm layer.
The regression equation was obtained by the 
method of least squares for n=8. Regression equation: 
Y = slope*x + intercept. Slope, intercept and correla-
tion coefficient were determined from the regression 
analysis calculations in Microsoft Excel 2007 (13).
Using this linear equation, correlation coeffi-
cient (r2) and the detection limits were determined. 
Accuracy: mean ± SD; Linearity (lowest – highest 
concentration while curve is linear); SE of intercept: 
, 
where Y - standard concentration, Y’ - found 
concentration; SD of intercept: SE of intercept*√n
The limit of detection (LOD): 3.3*(SD of inter-
cept / slope); and the limit of quantitation (LOQ): 
10*(SD of intercept / slope). The LOD was defined 
by the concentration with a signal-to-noise ratio of 
3. The analyte peak in the LOQ sample should be 
identifiable, discrete, and reproducible with a preci-
sion of ±20% and accuracy within 80%–120%. The 
deviation of standards other than LOQ should not be 
more than ±15% of the nominal concentration. 
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Precision (repeatability of the method) was 
evaluated by repeated absorption detection and the 
results were expressed as the mean standard devia-
tion (SD) and the percent relative standard deviation 
RSD (%) = SD/Mean. For intraday analysis the sam-
ples were analyzed six times a day at 09:00 am, 11:00 
am, 01:00 pm, 03:00 pm, 05:00 pm, and 07:00 pm, 
while for interday stability it was analyzed for 6 con-
secutive days at 09:00 am.
RESULTS AND DISCUSSION
In the literature data it is reported, that clopido-
grel UV-determination followed Beer’s law at the 270 
nm in the concentration range 5-45µg/ml in meth-
anol diluted with phosphate buffer (14). It was also 
estimated at the 219nm in 0.1 N HCl solution with 
10-30μg/ml concentration (15). Cholke PB et al. used 
triple distilled water pH 1 with 40-70µg/ml of clopi- dogrel bisulfate with wavelength of detection 222nm (16).
Fig. 2. The maximum absorbance at the wavelength of 
the 203 nm in the UV spectrum of clopidogrel in 0.002% 
methanol solution










1 50 0.05 2.0588 24.29 d- -
2 4 0.004 1.7402 2.30 - -
3 2.8 0.0028 1.3912 2.01 - -
e4 2.6 0.0026 1.3561 1.92 2.5811 99.2723
5 2.4 0.0024 1.2401 1.94 2.3436 97.64879
6 2 0.002 1.1127 1.80 2.0827 104.1360
7 1.8 0.0018 0.9861 1.83 1.8235 101.3059
8 1.6 0.0016 0.8759 1.83 1.5979 99.8669
9 1.4 0.0014 0.7852 1.78 1.4122 100.8687
10 1.2 0.0012 0.6933 1.73 1.2240 101.9997
11 1 0.001 0.5525 1.81 0.9357 93.5708
12 0.8 0.0008 0.4170 1.92 - -
13 0.6 0.0006 0.3057 1.96 - -
14 0.4 0.0004 0.1728 2.31 - -
15 0.2 0.0002 0.0649 3.08 - -






a E –percent solution extinction coefficient = Conc. stand., mg/100 mL/Absorbance;
bFound concentration: (Absorbance – intercept)/slope;
cRecovery: found concentration / labeled concentration*100;
d not tested;
e bold values - the concentration range with the best calculated linearity.
Table 1. Concentration of standard clopidogrel solutions in methanol, their absorbencies, accuracy and recovery data
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In our case, we aimed to conduct the experi-
ment in the conditions that will be closest for the 
next dialysis investigations (pH about 6,7) with low 
concentrations of clopidogrel, and easy dilution pro-
cess and relative cheapness. Different organic sol-
vents like methanol, ethanol, n-propanol, isopropa-
nol and n-butanol were tested for the investigation. 
However, the best linear correlation of maximum 
UV absorbance with concentration was achieved 
only in a methanol solution.
Analyzing clopidogrel absorbance maximums, 
two of them were detected in the UV spectrum: the 
202-204 and the 270-271nm. Besides, in the inves-
tigated concentration ranges (12-14µg/mL) no oth-
er suitable absorbance maximums were found. And 
only at the wavelength of the 203nm the Beer’s law 
was followed. Even if this peak was situated in the 
spectrum area where it could be overlapped with 
benzene rings absorbencies of other ingredients, the 
intent of the given study was development of the fast 
and low-cost method for pure substance of clopido-
grel evaluation (Fig. 2).
Validation of the method was prepared in ac-
cordance with the validation parameters of the ana-
lytical methods (17).
The fifteen working standard solutions were 
obtained from the main standard solution (0.05%) 
and their absorption was measured at the 203nm.
The appropriate percent solution extinction co-
efficients, accuracy and recovery data in percentage 
are given in Table 1.
The linearity was evaluated by linear regression 
analysis, which was calculated by the least-square re-
gression analysis. According to the percent solution 
extinction and regression coefficients, the calibration 
curve of clopidogrel with good linearity (r2=0.9929) 
was found in the concentration range 1.0-2.6 mg/100 
mL (solutions 4-11) (Table 2, Fig. 3).
The accuracy of the method was proven by cal-
culating the recovery at eight different concentra-
tions of the calibration range marked with bold num-
bers in the Table 1 (99.83±3.18%). The mean percent-
age of recoveries was found to be 99.98±2.98%.
The presented curve could be used for simple 
and fast evaluation of unknown clopidogrel sample 
quantity after appropriate dilution in methanol.
Slope, intercept and correlation coefficient were 
determined from the regression analysis calculations 
(Table 2).
The limit of detection (LOD) was found to be 
0.59μg/100mL, while the limit of quantification 
(LOQ) was 1.78μg/100mL.
The ruggedness of the method was determined 
by performing the same assay by different scientists 
and performing the assay on different days to check 
the reproducibility. The results were found to be 
highly reproducible during the day – RSD was 0.83%, 
but during the week it deteriorated to 4.12% (Table 3).
To determine the robustness of the method, ex-
perimental conditions like room temperature, ab-
sence of stirring or addition of ultrasound, as well as 
different methanol series were checked. It was found 
that usage of the cuvette without glass cap, due to 
methanol evaporation, affected the results negatively. 
Furthermore, it should be noted that without stirring 
clopidogrel bisulphate was distributed in the metha-




Linearity (mg/100 mL) 1.0-2.6
Regression equation y = 0.4884x-0.0955
r2 0.9929
SE of intercept 0.0307
SD of intercept 0.0869
LOD (μg/100 mL) 0.5875
LOQ (μg/100 mL) 1.7802
Table 2. Linearity data, accuracy and precision of 
clopidogrel in methanol
Fig. 3. Calibration curve of clopidogrel
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dogrel destruction, because final results were of low-
er values. So, ordinary physical stirring and temper-
ature of 20°C were the most important factors to ob-
tain accurate data.
Hence, to detect the amount of clopidoglel bisul-
phate in pure substance the next method is proposed.
0.0500 of clopidogrel bisulphate was quanti-
tatively placed in the 100.0mL flask, dissolved with 
methanol to obtain 0.05% solution and stirred for 
15min. Then 2.00mL of the obtained solution was 
quantitatively transferred in the 50.0mL flask and 
methanol was added to obtain 0.002% one and 
stirred for 15min. 7.00mL of the solution was quan-
titatively transferred in the 10.00mL flask, methanol 
was added to obtain the final 0.0014% solution, then 
stirred for 15 min. The amount of clopidogrel bisul-
phate was determined by employing UV absorption 
at the wavelength of 203nm in comparison to metha-
nol in 3mL cuvette with 1 cm layer. 
The sample concentration was calculated in ac-
cordance with the next equation:




where Ai – absorbance of the investigated sam-
ple in methanol at the 203 nm in 3 mL cuvette with 
1 cm layer;
Or, in comparison to the measured absorbance 
of standard solution:
С, % of final solution 
7793.0
0014.0*Ai=
where Ai – absorbance of the investigated sam-
ple in methanol at the 203 nm in 3 mL cuvette with 
1 cm layer;
0.0014 - concentration (%) of the standard solu-
tion with absorbance of 0.7793 at the 203 nm (calcu-
lated according to the obtained regression equation).
or concentration in the initial sample:
С, % (w/V) in bulk 
where Ai –absorbance of the final experimen-
tal sample solution;
C0 – concentration of the clopidogrel sulphate 
standard solution is 0.0014, %;
100.0, 50.00, 10.00 – flasks dilutions volume, 
mL;
A0 – maximum absorbance of 0.0014% stan-
dard solution at the 203 nm is 0.7793, 
2.00, 7.00 – sample volume taken by pipette, 
mL;
l – cuvette layer, 1 cm;
a – sample weight, g.
CONCLUSIONS
It was found, that in a methanol solution clopi-
dogrel bisulphate could be simply, at a low-cost, fast 
and accurately qualitatively and quantitatively deter-
mined by UV spectroscopy in the pure substance by 
the maximum absorbance at the 203nm. Validation 
of the proposed method showed, that the calibration 
curve had good linearity (r2=0.9929) in the concen-
tration range 1.0-2.6mg/100mL. The LOD was found 
to be 0.59mg/100mL, and LOQ was 1.78mg/100mL. 
Such criteria like accuracy, precision, robustness and 
ruggedness also showed high validity and reproduc-
ibility of the method, noticing the high importance 
of ordinary stirring and 20°C temperature. The pro-
posed technique could be successfully used for the 
determination of clopidogrel bisulphate in the con-
ditions of the smallest laboratories without LC−MS 
spectrometer or HPLC-UV chromatograph in the 
















Table 3. Intraday and interday precision data of 0.002% 
clopidogrel methanol solution
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el methods of pharmacokinetic studies in the phar-
maceutical dosage forms.
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